NCT07319390

Brief Summary

The aim of this study will be to compare between MTP and ESPB in terms of postoperative pain score in patients undergoing laparoscopic sleeve gastrectomy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 3, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 5, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 6, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 14, 2026

Completed
18 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

5 months

First QC Date

December 5, 2025

Last Update Submit

April 2, 2026

Conditions

Bariatric Sleeve Gastrectomy

Outcome Measures

Primary Outcomes (1)

  • Mean postoperative pain numeric rating scale

    Abdominal pain will be assessed using numeric rating scale which includes 10 degrees of which zero is no pain and 10 is maximum pain ever

    pain will be evaluated first in postanesthesia care unit then at 1, 3, 6, 8, 12, 18, 24 hours posoperative

Study Arms (2)

Group A (ESPB): Bilateral ESP

ACTIVE COMPARATOR

block at T7 with 20 mL of 0.25% bupivacaine on each side

Procedure: Erector Spinae Plane Block (ESPB) group

Group B (MTPB): Bilateral MTP

ACTIVE COMPARATOR

block at T7 with 20 mL of 0.25% bupivacaine on each side

Procedure: Midpoint Transverse Process to Pleura Block (MTPPB)

Interventions

Erector Spinae Plane Block (ESPB) groupPROCEDURE

will receive ESPB volume of 20 mls bupivacaine 0.25 % at level T7 bilaterally

Group A (ESPB): Bilateral ESP
Midpoint Transverse Process to Pleura Block (MTPPB)PROCEDURE

will receive MTPB volume of 20 mls bupivacaine 0.25 % at level T7 bilaterally

Group B (MTPB): Bilateral MTP

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Anesthesiologists (ASA) physical status II, of either sex Age ≥18 y.
  • Undergoing laparoscopic sleeve gastrectomy
  • BMI≥ 35

You may not qualify if:

  • Patient refusal to give consent for the block
  • Hypersensitivity to any of study medications
  • Infection at site of the block
  • Coagulopathy
  • severe cardiac/hepatic/renal disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams university hospitals

Cairo, 11591, Egypt

Location

MeSH Terms

Interventions

Population Groups

Intervention Hierarchy (Ancestors)

DemographyPopulation Characteristics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
the patient and data collector won't know type of the block received
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2025

First Posted

January 6, 2026

Study Start

October 3, 2025

Primary Completion

March 14, 2026

Study Completion

April 1, 2026

Last Updated

April 8, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations

EG(1)